🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
Triple-negative breast cancer (TNBC) is among the most aggressive and letha...
Status
Recruiting
Location
Fondazione IRCCS San Gerardo Dei Tintori
Start Date
2025-03-06
Trial ID
NCT06690840
Treatments Being Tested
To learn if atezolizumab in combination with oxaliplatin and 5-fluorouracil...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-02-19
Trial ID
NCT03784326
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
This phase II trial studies the effect of lamivudine in combination with st...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2021-07-02
Trial ID
NCT04696575
Treatments Being Tested
This phase II trial tests how well trabedersen (OT-101) in combination with...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-01
Trial ID
NCT05935774
A Phase 1a/1b, multicenter, open-label, non-randomized, dose-escalation, an...
Status
Completed
Location
Fox Chase Cancer Center
Start Date
2019-09-23
Trial ID
NCT04096638
Treatments Being Tested
This study aims to determine the safety and tolerability of combined Atezol...
Status
Recruiting
Location
Chilldren's Healthcare of Atlanta
Start Date
2026-07
Trial ID
NCT06492954
Treatments Being Tested
This phase II trial studies how well atezolizumab, cobimetinib, and eribuli...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-11
Trial ID
NCT03202316
Treatments Being Tested